These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21853288)

  • 1. Variant in the 3' region of SNCA associated with Parkinson's disease and serum α-synuclein levels.
    Hu Y; Tang B; Guo J; Wu X; Sun Q; Shi C; Hu L; Wang C; Wang L; Tan L; Shen L; Yan X; Zhang H
    J Neurol; 2012 Mar; 259(3):497-504. PubMed ID: 21853288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.
    Cardo LF; Coto E; de Mena L; Ribacoba R; Mata IF; Menéndez M; Moris G; Alvarez V
    Neurosci Lett; 2014 Mar; 562():45-9. PubMed ID: 24418406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
    Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
    PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
    Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
    J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein and Parkinsonism: Updates and Future Perspectives.
    Rosborough K; Patel N; Kalia LV
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):31. PubMed ID: 28324300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Link between the SNCA gene and parkinsonism.
    Xu W; Tan L; Yu JT
    Neurobiol Aging; 2015 Mar; 36(3):1505-18. PubMed ID: 25554495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
    Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
    Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
    Gámez-Valero A; Canet-Pons J; Urbizu A; Anillo A; Santos C; Ariza A; Beyer K
    J Alzheimers Dis; 2018; 65(1):207-219. PubMed ID: 30040713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.
    Blažeković A; Jerčić KG; Borovečki F
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
    Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
    Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson's disease: an updated meta-analysis of 41,811 patients.
    Du B; Xue Q; Liang C; Fan C; Liang M; Zhang Y; Bi X; Hou L
    Neurol Sci; 2020 Feb; 41(2):271-280. PubMed ID: 31758346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.
    Schmitt I; Wüllner U; van Rooyen JP; Khazneh H; Becker J; Volk A; Kubisch C; Becker T; Kostic VS; Klein C; Ramirez A
    Eur J Hum Genet; 2012 Dec; 20(12):1265-9. PubMed ID: 22617348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
    Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
    Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
    FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.
    Taymans JM; Cookson MR
    Bioessays; 2010 Mar; 32(3):227-235. PubMed ID: 20127702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.